# FDA Inspection 1119126 - Biomat USA Inc (Birmingham Location #2) - January 16, 2020

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc-birmingham-location-2/615f2f6d-9501-4ae8-b835-89d335342bac
Source feed: FDA_Inspections

> FDA Inspection 1119126 for Biomat USA Inc (Birmingham Location #2) on January 16, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1119126
- Company Name: Biomat USA Inc (Birmingham Location #2)
- Inspection Date: 2020-01-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1008953 - 2017-04-25](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc-birmingham-location-2/ab371986-80f2-4dce-a6d9-15c014a5441a)
- [FDA Inspection 932135 - 2015-06-25](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc-birmingham-location-2/a01ffc62-b779-4607-ad4f-dd62e68cd123)
- [FDA Inspection 774401 - 2012-03-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc-birmingham-location-2/1a17fb57-e765-442d-8e74-ce9104174dc9)
- [FDA Inspection 569284 - 2009-03-13](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc-birmingham-location-2/a99d8468-726a-4589-9a3c-69907371bbd0)

Company: https://www.keypedia.com/companies/biomat-usa-inc-birmingham-location-2/20e4102d-14d9-4083-88c9-6a1930f68de7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d